CEREBROVASCULAR diseases rank as the third most common cause of death in the United States. In recent years the long-term downward trend in stroke mortality appears to have accelerated; death rates for stroke have declined more rapidly than for any other component of cardiovascular mortality. This paper presents data on the trends in stroke mortality for the 4 major sex-color groups and discusses possible causative mechanisms.
Ratios of white to non-white mortality were based on the age-adjusted rates for the entire age range.
Mortality data from each of the 50 states were combined to form the 9 standard geographic regions routinely presented by the National Center for Health Statistics (Appendix I). The 7 even numbered years between 1960 and 1974 were analyzed for the 9 regions. Complete data were not available on the population base by region and age adjustment was based on 3 age categories: 0-44, 45-64, 65 and over. Population data by sex and color were also unavailable for the geographic regions.
Cause of death for mortality statistics was coded according to the Seventh Revision of the International Classification of Disease (ICD) from 1958 through 1967, and according to the Eighth Revision of the ICD from 1968 to 1974. The Seventh Revision rubric for stroke included ICD Nos. 330-334, Vascular Lesions Affecting the Central Nervous System, and was transferred in the Eighth Revision to Diseases of the Circulatory System, Cerebrovascular Diseases, ICD Nos. 430-438. The comparability ratio for the change of classification from the Seventh to the Eighth Revisions was estimated as 0.981 by the National Center for Health Statistics. 2 The comparability ratio was not used for this analysis and the data are considered as part of a continuous trend.
Mortality for each sex-color group from Coronary Heart Disease and Hypertensive Heart Disease (8th Revision Nos. 410-413 and 402,404, respectively) are also considered for certain periods, to place stroke mortality in perspective.
Results

Mortality Trends for Stroke in the United States
Mortality data on cerebrovascular diseases have been available from selected states since 1914. Beginning with 1933 all states and the District of Columbia were reporting death rates from this cause by age, color and sex.
As previously reported, 1 a continuous decline in age-adjusted stroke death rates has been recorded since the 1920's for 3 of the 4 sex-color groups, i.e., all except non-white males. The rates for non-white males did not begin to fall until 1930 and had dropped only modestly through the mid-1960's. With account taken of changes in classification, from 1914 to 1960 death rates from stroke decreased 44 percent for white males, 51 percent for white females, 27 percent for non-white females and only 12 percent for non-white males. 1 By 1960 rates for non-white females had declined to a level roughly equal to rates for non-white males (table 1) , and both were approximately 50 percent greater than rates for whites. The gradual downward trend for each sex-color group continued through 1968 (table 1, fig. 1 ). As is described subsequently, general mortality and mortality from cardiovascular diseases in particular reflect short-term fluctuations in the death rates from influenza and pneumonia. The influences of influenza outbreaks on stroke death rates are indicated by the data for the years 1963 and 1968.
From 1968 to 1975 the fall in mortality greatly accelerated, with twice the percentage decline of the years 1960-67 (table 2) . However, for white males the increased rate of decline did not begin until the last 4 years, resulting in the least total decline of the 4 sexcolor groups. The difference in the slopes of the mortality curves for the periods 1960-1967 and 1968-1975 was statistically significant for 3 of the 4 groups, i.e., all except white males (table 2) . Each sex-color group dropped more than 20 percent in the most recent 8 year period, with the decline for non-whites almost equaling that of the previous half century. The trend for the 2 sexes in each color group closely paralleled each other, black greater than white (cf. slopes, 1968-1975 , table 2) . By 1975 the age-adjusted rates of both non-white sexes had fallen just below the rates for the respective white sex in 1960.
Despite continued aging of the population, crude death rates also fell significantly from 1968 to 1975 (table 3) . (The fact that the non-white population is younger than the white accounts for the absence of higher rates for the non-whites compared to the whites.)
The strikingly higher death rates from stroke among non-whites (overwhelmingly blacks) compared to whites has been a constant and well recognized figure  2 . Although the different basis for age-adjustment prevents direct comparison, it would appear that the decline in rates for this age group is greater than for Given the importance of stroke as a cause of mortality, particularly for non-white females in this age range, the 48.5 percent decline in death rate recorded over the period 1960-1975 apparently represents a fundamental change in the pattern of this disease. Age specific stroke mortality rates, presented in the Appendix, (tables A1-A4) confirm the findings of the broader age groups. Sizeable geographic differences in death rates from cerebrovascular diseases have been recorded consistently in the United States. 17 Although regional variations in diagnostic practices could presumably be a confounding factor, national cooperative studies have confirmed the findings of routine vital statistics. 8 Trends in the 9 geographic regions of the U.S. from 1960 to 1974 are presented in table 7. A drop in the rates was reported in every region. The 2 greatest declines were for the South Atlantic and New England regions, having among the highest and lowest rates respectively in 1960. Overall the rates tended to converge, with less variation from region to region in 1974 than 1960 (coefficient of variation 13.5 and 12.5 respectively, and range 48.2 and 37.4 respectively).
Lives Saved by the Decline in Mortality Rates
The impact of the falling mortality rates from cerebrovascular diseases from 1960 to 1975 can be estimated by applying the 1960 age-specific rates to the appropriate age category in 1975 (table 8) . Considering the entire population, an additional 86,700 persons would have died from stroke in 1975 if the 1960 rates had persisted.
Discussion
The central finding of this study is an accelerated decline in stroke mortality rates, age-specific and ageadjusted, for all 4 major sex-color groups in the United States over the years [1968] [1969] [1970] [1971] [1972] [1973] [1974] [1975] , substantial in percentage, somewhat greater for non-whites than whites, and indicative of a substantial saving of lives among the middle-aged and aging strata of the population.
Epidemiologic analyses of vital statistics data must always contend with the problem of their validity. The antemortem diagnosis of stroke rests primarily on the evaluation of signs and symptoms rather than on laboratory measurements. 9 Furthermore, the observed clinical event localizes the site of the lesion rather than its cause. Other forms of cardiovascular disease, particularly hypertension, often accompany stroke, 10 and the designation of cause of death depends on the judgment of the certifying physician, medical examiner or coroner's physician. Diagnostic fashions in death certification change over time. The significance of secular trends of sub-categories of the cerebrovascular diseases -not attempted in this study -is especially open to serious question, given the difficulties often present in distinguishing among atherothrombotic brain infarction, embolism, intracerebral and subarachnoid hemorrhage. 1 
'
n Even considering deaths from the cerebrovascular diseases as a single entity, as was done in this report, the possibility exists that the burden of stroke deaths could have been shifted to other rubrics of the cardiovascular disease classification. Fortunately, the overall available data indicate that this potential problem of bias due to possible drift in the pattern of classifying mortality is not of decisive importance in accounting for the trends of stroke mortality from 1968 to 1975. Thus these years witnessed parallel sizeable declines in the mortality rates from the other cardiovascular diseases, and from all causes as well. The adoption of the Eighth Revision of the ICD in 1968 created a major break in the method of coding deaths from Hypertensive Heart Disease (HHD) and Coronary Heart Disease (CHD), 2 making it difficult to examine trends across that time line. But for the period since 1968, when the greatest changes have been recorded, the declines in mortality coded to CHD (ICD Nos. 410-413) and HHD (ICD Nos. 402, 404) are very similar to the trends for stroke. 12 The relatively greater improvement in mortality recorded for non-whites is apparent for these causes as well. For the entire population, white and non-white combined, the age-adjusted rates for CHD fell 19 percent while deaths from HHD dropped 47 percent from 1968 to 1975.
As noted previously, death rates from cardiovascular diseases are influenced by cycles of epidemic respiratory infection.
:3t u Following the relatively severe epidemic of 1968, age-adjusted mortality rates from influenza and pneumonia (ICD Nos. 470-474, 480-486) fell considerably through 1975: 32 percent for white males, 38 percent for white females, 45 percent for non-white males, 55 percent for non-white females. Gordon and Thorn have previously discussed the possible impact of this phenomenon on mortality from CHD, 14 and stroke deaths may have also been influenced by this trend. Since 1968 mortality from stroke has declined every year for each of the 4 sexcolor groups with very similar percentage change in the last 4 years (table 2). Prior to that period the pattern was less consistent, particularly for non-white males. A broad change in general mortality, rather than an abrupt amelioration of any specific disease process relating to death from stroke, could be responsible for this phenomenon. It is also possible that a decline in the number of high-risk individuals in the population, e.g., persons who suffered a non-fatal stroke, could, in part, account for the fall in death rate from respiratory infection. Such a mechanism would explain why the susceptibility to death from respiratory infection among non-whites has decreased so dramatically relative to whites. Unfortunately, the available data do not allow a test of that hypothesis.
In addition to the possible waning impact of extraneous causes of stroke mortality, etiologic factors must be examined to assess their role in the observed secular trends. Identification of risk factors for stroke has made considerable progress though the data base is less extensive than for CHD.
1 ' 10 -1617 The risk of dying from stroke is most clearly related to hypertension, with a smaller contribution from the other established major cardiovascular risk factors. 15 - 16 Death rates from stroke have been falling in this country since at least 1914.' Unfortunately, data recording trends in the prevalence of hypertension have not been collected. Comparisons of the national surveys carried out in 1960-1962 and 1971-1974 demonstrate that the prevalence of definite hypertension among adults age 18-74 has not changed. 18 At least since 1968, however, it would appear that the detection, treatment, and control of hypertension have improved markedly.
19
" 22 The benefits of hypertension control are also consistent with the mortality trends outlined above -a greater decline in disease categories linked most closely to hypertension, and among groups in the population with the highest prevalence of hypertension.
To establish a crude estimate of the potential effectiveness of hypertension control, the benefit of treatment demonstrated in randomized trials can be applied to the community surveys. In the Veterans Administration Cooperative Study 23 7 of 194 control and only 1 of 186 treated patients died of stroke during the approximately 4 years of follow up. Effectiveness of treatment, calculated as the difference in percent incidence between control and treated groups divided by percent incidence in the control group, was 85 percent. Community surveys have shown an increase from about 12 percent to 40 percent of hypertensives controlled since 1968.
"
22 Population attributable risk for a cerebrovascular event in persons diagnosed as hypertensive was 43 percent of the total risk, calculated from Framingham data on persons age 45-74 (table 8, ref. 16) . Combining the estimates that antihypertensive therapy would be 85 percent effective in eliminating the 40 percent of the population risk attributable to hypertension, and accepting an increase in 28 percent of hypertensives now controlled, a 10 percent decline in rates could be expected. In fact, the age-adjusted decline for the U.S. population over the comparable period, 1970-1974, was 10 percent. Obviously, these comparisons are of only a general nature. The assumptions required to apply the data from the VA trials and the Framingham study to the general population have many potential weaknesses. It must also be remembered that a long-term decline in stroke mortality has been occurring at a rate of about 1 percent a year; the benefit of antihypertensive treatment could only be attributed to decline over and above that rate, roughly 5 percent for the 4 years examined here. The increasing rate of decline is consistent with a cumulative effect of blood pressure control. In addition, the prevalence of other risk factors for atherosclerosis -e.g., cigarette smoking and hypercholesterolemia -does appear to have declined modestly over the last decade as well.' 2 5 The consistency of the accelerated decline in stroke deaths in the U.S. by age, sex, color and geographic region, strongly suggest that a new secular trend has developed. A similar pattern observed for all major cardiovascular diseases reinforces this judgment. By their very nature, data on free-living populations are not collected in controlled, experimental form, and causative relationships between medical treatment and mortality rates are often difficult to establish. Indirect evidence, however, supports the contention that improved detection, treatment, and control of hypertension has been an important contributing factor to the recent fall in stroke death rates. Continued and increased efforts to detect and treat hypertension and other risk factors should result in further control of 
